Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T30778 |
CCG-257081
MRTF/SRF-IN-1,CCG257081,CCG 257081 |
Rho; Ras | Cell Cycle/Checkpoint; GPCR/G Protein; MAPK |
CCG-257081 (MRTF/SRF-IN-1) 是心肌素相关转录因子和血清反应因子 (MRTF/SRF) 的抑制剂,通过抑制 Rho/MRTF/SRF 通路来发挥作用。CCG-257081 已在多个小鼠模型中显示出预防博莱霉素诱导的纤维化的功效。CCG-257081 可用于预防癌症和纤维化的研究。 | |||
T80568 |
Casdozokitug
SRF-388 |
||
Casdozokitug (SRF-388) 是一种针对IL27的IgG1κ类型抗体。 | |||
T22062 |
CCG-100602
|
Rho; Ras | Cell Cycle/Checkpoint; GPCR/G Protein; MAPK |
CCG-100602 是心肌蛋白相关转录因子 A/血清反应因子信号转导的特异性抑制剂。它抑制 PC-3 前列腺癌细胞中 RhoA/C 介导的、SRF 驱动的荧光素酶表达,IC50为 9.8 µM。 | |||
T4306 |
CCG-203971
CCG203971 |
Rho; Ras | Cell Cycle/Checkpoint; GPCR/G Protein; MAPK |
CCG-203971 是一种Rho/MRTF/SRF 通路抑制剂,具有潜在的抗转移作用。它有效靶向 RhoA/C 激活的 SRE 荧光素酶,IC50为 6.4 μM。它抑制 PC-3 细胞迁移,IC50为 4.2 μM。 | |||
T2014 |
CCG-1423
CCG1423 |
LRRK2; Rho; Ras | Autophagy; Cell Cycle/Checkpoint; GPCR/G Protein; MAPK |
CCG-1423 是一种选择性 RhoA 通路抑制剂,可抑制 SRF 介导的转录,能抑制细胞的转移前列腺癌PC-3细胞侵袭模型。 | |||
T26967 |
CCG-232601
CCG 232601,CCG232601 |
||
CCG-232601 is a inhibitor of the Rho/MRTF/SRF transcriptional pathway. | |||
T68431 |
CCG-58150
|
||
CCG-58150 is a potentiInhibitor of Rho/Myocardin-Related Transcription Factor (MRTF)/Serum Response Factor (SRF)-Mediated Gene Transcription as Potential Antifibrotic Agents for Scleroderma. | |||
T82766 | CCG-232964 | ROCK | Cell Cycle/Checkpoint; Cytoskeletal Signaling; Stem Cells |
CCG-232964为口服活性Rho/MRTF/SRF抑制剂,能够抑制LPA诱导的CTGF基因表达。 | |||
T23221 |
(R)-CCG-1423
|
Others | Others |
(R)-CCG-1423 is a stereoisomer of CCG-1423. CCG-1423 is a Rho inhibitor involved in blocking signaling through myocardin-related transcription factor A (MRTF-A) and serum response factor (SRF). |